Patent · US Active

6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists

US8022062B2 · kind B2 · utility

2Cited by

2References

22Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

John Gordon Allen · Newbury Park, US
Karin Briner · Indianapolis, US
Michael Philip Cohen · Indianapolis, US
Christopher Stanley Galka · Carmel, US
Sarah Lynne Hellman · Indianapolis, US
Maria Angeles Martinez-Grau · Madrid, ES
Matthew Robert Reinhard · Indianapolis, US
Michael Rodriguez · Arlington Heights, US
Roger Ryan Rothhaar · Reelsville, US
Michael Wade Tidwell · Lakehills, US
Frantz Victor · Indianapolis, US
Andrew Caerwyn Williams · Reading, GB
Deyi Zhang · Carmel, US
Michael Philip Mazanetz · Abingdon, GB

Key dates

Filing date	Feb 18, 2005
Grant date	Sep 20, 2011
Priority date	—
Expiry date	Nov 24, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H-benzo[d]azepines of Formula I as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.